An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device
about
Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple SclerosisUsability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population.Subcutaneous Interferon β-1a Administration by Electronic Auto-injector is Associated with High Adherence in Patients with Relapsing Remitting Multiple Sclerosis in a Real-life Study.Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart® in patients with multiple sclerosis.Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis.Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study.Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study.Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study.
P2860
Q28597830-623DD0D3-2DBC-4B0A-A747-DBCD807EAB7EQ35703723-D4617889-FB8A-437A-B6D1-118D952F536FQ37681428-18303903-DC6D-468E-97F1-B71A311A0B9FQ37682836-ED6F97FF-C905-47E7-B0F5-FAB4100D18B4Q38661416-1E25A37E-4758-4845-AB1C-9F7944E952EAQ39962881-9C1BEBF3-A7C6-4463-8A78-3BEB63C3448FQ39973284-D762A11D-4BDD-4C76-895E-6D7B01450788Q40538397-5643D6A7-495B-4984-8B79-466205B2E30BQ41594556-0922EC3F-FC0A-4BA1-A551-0A252D4D2E55Q44073784-2BDDD0BD-EAA7-490E-953B-DF6C4ECCDFEFQ47282950-07751682-89F2-41C2-9CD6-335D04EAFAD4
P2860
An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An observational, retrospectiv ...... RebiSmart(®) injection device
@ast
An observational, retrospectiv ...... RebiSmart(®) injection device
@en
type
label
An observational, retrospectiv ...... RebiSmart(®) injection device
@ast
An observational, retrospectiv ...... RebiSmart(®) injection device
@en
prefLabel
An observational, retrospectiv ...... RebiSmart(®) injection device
@ast
An observational, retrospectiv ...... RebiSmart(®) injection device
@en
P2093
P2860
P356
P1476
An observational, retrospectiv ...... RebiSmart(®) injection device
@en
P2093
Anne Marie Larkin
Helen Willis
Julie Webster
Laura Parkes
P2860
P304
P356
10.2147/PPA.S54986
P407
P577
2014-06-12T00:00:00Z